Market Overview

Auriga Raises PT on Cavium to $41

Auriga has raised the price target on Cavium (NASDAQ: CAVM) from $37 to $41 and maintains its Buy rating.

Posted-In: AurigaPrice Target Pre-Market Outlook Analyst Ratings

 

Related Articles (CAVM)

Around the Web, We're Loving...

Get Benzinga's Newsletters